G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development

The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone (New York, N.Y.) N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332
Hauptverfasser: Ideno, Hisashi, Nakashima, Kazuhisa, Komatsu, Koichiro, Araki, Ryoko, Abe, Masumi, Arai, Yoshinori, Kimura, Hiroshi, Shinkai, Yoichi, Tachibana, Makoto, Nifuji, Akira
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 115332
container_issue
container_start_page 115332
container_title Bone (New York, N.Y.)
container_volume 137
creator Ideno, Hisashi
Nakashima, Kazuhisa
Komatsu, Koichiro
Araki, Ryoko
Abe, Masumi
Arai, Yoshinori
Kimura, Hiroshi
Shinkai, Yoichi
Tachibana, Makoto
Nifuji, Akira
description The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2. •G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.
doi_str_mv 10.1016/j.bone.2020.115332
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2396307405</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328220301125</els_id><sourcerecordid>2396307405</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AQ-So5eu-WjTLngR8QsEQfQc0mSym6VN1qQt-u_t2tWjpxnmfeYd5kXonJI5JVRcred18DBnhI0DWnDO9tCMViXPWCn4PppVZSEyzip2hI5TWhNC-KKkh-iIM57nlLAZSg8LhV3Czg-hGcCMDe5WgCMs-0Z1LngcLNZReacavL2HbYjtpHSrGPrlCivdueEPfu39J8O29_pnYvro_BIbGKAJmxZ8d4oOrGoSnO3qCXq_v3u7fcyeXx6ebm-eM50L0WXlouICbEksq43RtlK5YEoLBVQZYQgUCojNC6EZJ1bUo5rXKlelKCpSC85P0OXku4nho4fUydYlDU2jPIQ-ScYXgpMyJ8WIsgnVMaQUwcpNdK2KX5ISuQ1bruX2ebkNW05hj0sXO_--bsH8rfymOwLXEwDjl4ODKJN24DUYF0F30gT3n_83ITqR8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2396307405</pqid></control><display><type>article</type><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</creator><creatorcontrib>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</creatorcontrib><description>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2. •G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</description><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2020.115332</identifier><identifier>PMID: 32344102</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cell Differentiation ; Core Binding Factor Alpha 1 Subunit - genetics ; Cranial bone ; Epigenetics ; Histone methyltransferase ; Histone-Lysine N-Methyltransferase ; Mice ; Osteoblasts ; Osteogenesis ; Promoter Regions, Genetic ; Runx2 ; Skull</subject><ispartof>Bone (New York, N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</citedby><cites>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</cites><orcidid>0000-0002-8182-4380</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bone.2020.115332$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32344102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ideno, Hisashi</creatorcontrib><creatorcontrib>Nakashima, Kazuhisa</creatorcontrib><creatorcontrib>Komatsu, Koichiro</creatorcontrib><creatorcontrib>Araki, Ryoko</creatorcontrib><creatorcontrib>Abe, Masumi</creatorcontrib><creatorcontrib>Arai, Yoshinori</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shinkai, Yoichi</creatorcontrib><creatorcontrib>Tachibana, Makoto</creatorcontrib><creatorcontrib>Nifuji, Akira</creatorcontrib><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><title>Bone (New York, N.Y.)</title><addtitle>Bone</addtitle><description>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2. •G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</description><subject>Animals</subject><subject>Cell Differentiation</subject><subject>Core Binding Factor Alpha 1 Subunit - genetics</subject><subject>Cranial bone</subject><subject>Epigenetics</subject><subject>Histone methyltransferase</subject><subject>Histone-Lysine N-Methyltransferase</subject><subject>Mice</subject><subject>Osteoblasts</subject><subject>Osteogenesis</subject><subject>Promoter Regions, Genetic</subject><subject>Runx2</subject><subject>Skull</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMoun78AQ-So5eu-WjTLngR8QsEQfQc0mSym6VN1qQt-u_t2tWjpxnmfeYd5kXonJI5JVRcred18DBnhI0DWnDO9tCMViXPWCn4PppVZSEyzip2hI5TWhNC-KKkh-iIM57nlLAZSg8LhV3Czg-hGcCMDe5WgCMs-0Z1LngcLNZReacavL2HbYjtpHSrGPrlCivdueEPfu39J8O29_pnYvro_BIbGKAJmxZ8d4oOrGoSnO3qCXq_v3u7fcyeXx6ebm-eM50L0WXlouICbEksq43RtlK5YEoLBVQZYQgUCojNC6EZJ1bUo5rXKlelKCpSC85P0OXku4nho4fUydYlDU2jPIQ-ScYXgpMyJ8WIsgnVMaQUwcpNdK2KX5ISuQ1bruX2ebkNW05hj0sXO_--bsH8rfymOwLXEwDjl4ODKJN24DUYF0F30gT3n_83ITqR8Q</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Ideno, Hisashi</creator><creator>Nakashima, Kazuhisa</creator><creator>Komatsu, Koichiro</creator><creator>Araki, Ryoko</creator><creator>Abe, Masumi</creator><creator>Arai, Yoshinori</creator><creator>Kimura, Hiroshi</creator><creator>Shinkai, Yoichi</creator><creator>Tachibana, Makoto</creator><creator>Nifuji, Akira</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8182-4380</orcidid></search><sort><creationdate>20200801</creationdate><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><author>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Cell Differentiation</topic><topic>Core Binding Factor Alpha 1 Subunit - genetics</topic><topic>Cranial bone</topic><topic>Epigenetics</topic><topic>Histone methyltransferase</topic><topic>Histone-Lysine N-Methyltransferase</topic><topic>Mice</topic><topic>Osteoblasts</topic><topic>Osteogenesis</topic><topic>Promoter Regions, Genetic</topic><topic>Runx2</topic><topic>Skull</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ideno, Hisashi</creatorcontrib><creatorcontrib>Nakashima, Kazuhisa</creatorcontrib><creatorcontrib>Komatsu, Koichiro</creatorcontrib><creatorcontrib>Araki, Ryoko</creatorcontrib><creatorcontrib>Abe, Masumi</creatorcontrib><creatorcontrib>Arai, Yoshinori</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shinkai, Yoichi</creatorcontrib><creatorcontrib>Tachibana, Makoto</creatorcontrib><creatorcontrib>Nifuji, Akira</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ideno, Hisashi</au><au>Nakashima, Kazuhisa</au><au>Komatsu, Koichiro</au><au>Araki, Ryoko</au><au>Abe, Masumi</au><au>Arai, Yoshinori</au><au>Kimura, Hiroshi</au><au>Shinkai, Yoichi</au><au>Tachibana, Makoto</au><au>Nifuji, Akira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</atitle><jtitle>Bone (New York, N.Y.)</jtitle><addtitle>Bone</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>137</volume><spage>115332</spage><epage>115332</epage><pages>115332-115332</pages><artnum>115332</artnum><issn>8756-3282</issn><eissn>1873-2763</eissn><abstract>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2. •G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32344102</pmid><doi>10.1016/j.bone.2020.115332</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8182-4380</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332
issn 8756-3282
1873-2763
language eng
recordid cdi_proquest_miscellaneous_2396307405
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Cell Differentiation
Core Binding Factor Alpha 1 Subunit - genetics
Cranial bone
Epigenetics
Histone methyltransferase
Histone-Lysine N-Methyltransferase
Mice
Osteoblasts
Osteogenesis
Promoter Regions, Genetic
Runx2
Skull
title G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A27%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=G9a%20is%20involved%20in%20the%20regulation%20of%20cranial%20bone%20formation%20through%20activation%20of%20Runx2%20function%20during%20development&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Ideno,%20Hisashi&rft.date=2020-08-01&rft.volume=137&rft.spage=115332&rft.epage=115332&rft.pages=115332-115332&rft.artnum=115332&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2020.115332&rft_dat=%3Cproquest_cross%3E2396307405%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2396307405&rft_id=info:pmid/32344102&rft_els_id=S8756328220301125&rfr_iscdi=true